THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC - TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.

On Jan 6, 2026, Department of Health and Human Services obligated $2,475,623 to THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC for to develop a novel modulator targeting proteostasis for the treatment of m. tuberculosis.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 18 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in NEW YORK, NY. The contract is scheduled through Nov 9, 2026 — approximately 5 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.